Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Greil

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Oncologist|July 2, 2024
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional studyJan Räder, Gabriele Ihorst, Mandy-Deborah Möller, et al.
Haematologica|September 22, 2018
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of lifeChristine Greil, Monika Engelhardt, Gabriele Ihorst, et al.
Frontiers in Oncology|September 6, 2021
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma PatientsVeronika Riebl, Sandra Maria Dold, Dagmar Wider, et al.
Haematologica|May 17, 2020
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trialSandra Maria Dold, Mandy-Deborah Möller, Gabriele Ihorst, et al.
British Journal of Haematology|July 30, 2025
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantationHartmut Bertz, Jörg Sahlmann, Donald C McMillan, et al.
Leukemia Research|June 1, 2016
Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesisChristoph Niemöller, Nathalie Renz, Sabine Bleul, et al.
Frontiers of Medicine|November 14, 2024
Enhancing patient activation: a controlled implementation study of an interprofessional evidence-based counseling program for complementary and integrative healthcare in cancer patients ('CCC-Integrativ')Jan Valentini, Daniela Froehlich, Inka Roesel, et al.
Annals of Hematology|December 4, 2022
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centersBenedikt Frank, Gabriele Ihorst, Georg Herget, et al.
Future Science OA|October 9, 2025
Personalized Combined Nutrition & Exercise Intervention in Newly Diagnosed Cancer Patients - a Trial ProtocolSebastian Theurich, Timo Niels, Hansjoerg Baurecht, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2023
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trialsIlinca Popp, Rianne D W Vaes, Lotte Wieten, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Oncologist|July 2, 2024
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional studyJan Räder, Gabriele Ihorst, Mandy-Deborah Möller, et al.
Haematologica|September 22, 2018
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of lifeChristine Greil, Monika Engelhardt, Gabriele Ihorst, et al.
Frontiers in Oncology|September 6, 2021
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma PatientsVeronika Riebl, Sandra Maria Dold, Dagmar Wider, et al.
Haematologica|May 17, 2020
Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trialSandra Maria Dold, Mandy-Deborah Möller, Gabriele Ihorst, et al.
British Journal of Haematology|July 30, 2025
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantationHartmut Bertz, Jörg Sahlmann, Donald C McMillan, et al.
Leukemia Research|June 1, 2016
Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesisChristoph Niemöller, Nathalie Renz, Sabine Bleul, et al.
Frontiers of Medicine|November 14, 2024
Enhancing patient activation: a controlled implementation study of an interprofessional evidence-based counseling program for complementary and integrative healthcare in cancer patients ('CCC-Integrativ')Jan Valentini, Daniela Froehlich, Inka Roesel, et al.
Annals of Hematology|December 4, 2022
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centersBenedikt Frank, Gabriele Ihorst, Georg Herget, et al.
Future Science OA|October 9, 2025
Personalized Combined Nutrition & Exercise Intervention in Newly Diagnosed Cancer Patients - a Trial ProtocolSebastian Theurich, Timo Niels, Hansjoerg Baurecht, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2023
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trialsIlinca Popp, Rianne D W Vaes, Lotte Wieten, et al.
Pageof 4